Sana Biotechnology Inc

Research Sana Biotechnology Inc (SANA) on Bullrun: market cap USD 960.11M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerSANA
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 960.11M
• Financial periodFY2025
• Net income-USD 244.17M
• Free cash flow-USD 144.77M

Valuation Snapshot

latest market cap is USD 960.11M.

About Sana Biotechnology Inc

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States. It develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including type 1 diabetes, B cell mediated autoimmune diseases, and oncology. The company's product pipeline includes UP421, a HIP-modified allogeneic primary islet cell product, which is in phase 1 clinical trial to treat type 1 diabetes;

Frequently asked questions

What is Sana Biotechnology Inc's market cap?

Sana Biotechnology Inc's market capitalization is USD 960.11M.

What does Sana Biotechnology Inc do?

Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines in the United States.